Testing effectiveness (Phase 2)Ended earlyNCT00441168
What this trial is testing
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 30